Fibromyalgia The opening research assessing Low Dose Naltrexone as an adjunct therapy in fibromyalgia was a single-blind, placebo-crossover study and included ten women undergoing the condition. After the initial couple weeks of placebo, LDN was given for eight weeks in a 4.5 mg dose with a subset.
CLINICAL OF LOW DOSE NALTREXONE IN TREATING FIBROMYALGIA AND COMPLEX REGIONAL PAIN SYNDROME
Fibromyalgia The opening research assessing Low Dose Naltrexone as an adjunct therapy in fibromyalgia was a single-blind, placebo-crossover study and included ten women undergoing the condition. After the initial couple weeks of placebo, LDN was given for eight weeks in a 4.5 mg dose with a subset. Complex regional pain syndrome ” ( CRPS ) reflects characteristics of this Female health condition, and an effective approach to treat it is still a clinical challenge.
